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We have analyzed the amino acid sequences ituated around the putative proteolytic cleavage sites in twenty 
different biosynthetic precursors of peptide hormones by processing enzymes. The prediction of the prob- 
ability for forming secondary structures around the basic amino acids, constituting the cleavage sites, was 
made using the modified method of Chou and Fasman. The results indicate that the processing sequences 
which are cleaved in vivo, are in ail cases located inside regions with high B-turn formation probability or 
else immediately adjacent to these structures. The p-turn forming region at the cleavage locus, is flanked 
on both sides by amino acid sequences with a high probability for forming highly ordered structures, either 
/?-sheet or cc-helix. These conformational features are not found in precursors around dibasic pairs, i.e. puta- 
tive cleavage loci, but which are not cleaved in vivo and appear to be conserved. We hypothesize that p-turns 
including the basic amino acids doublets, flanked by highly ordered secondary structures (either b-sheet or 
a-helix) may constitute a minimal requirement for the recognition by the endoproteases involved in the pro- 
cessing of these precursors. 
Proteolytic processing 
1. INTRODUCTION 
Activation of precursor molecules by proteolytic 
processing is a quite largely expanded mechanism 
both in lower and higher organisms. This appears 
to be essential in the replication of picornaviruses 
[l], the activation of either plasma proteins or 
zymogens [2]. In the case of secretory proteins, 
conversion of the biosynthetic precursor into the 
biologically active form(s) is dependent upon post- 
translational modifications including proteolytic 
cleavage performed by presumed selective pro- 
teases. Examination of the amino acid sequences 
of prepro-peptide hormones as derived from the 
Abbreviations: H, E and T, a-helix, P-sheet and &turn 
structures; K and R, Lys and Arg amino acid residues, 
respectively 
Protease B-turn 
corresponding cloned cDNAs nucleotide sequences 
indicated that the biologically active hormone se- 
quence is always flanked, or preceded, by basic 
amino acids, Lys and/or Arg, often arranged as 
pairs or even quadruplets and sometime as a singlet 
or a triplet (see references in table 1). Since during 
processing these basic amino acids are completely 
removed from the precursor molecules and are 
generally no longer found in the ‘mature’ peptide 
hormones, this implies that an adequate and selec- 
tive enzyme equipment can excise these amino 
acids and that they probably participate in recogni- 
tion signals for these endoproteases. Examination 
of the amino acid sequences around these cleavage 
signals was unsuccessful in revealing the conserva- 
tion of any ‘consensus’ primary sequence and so 
raised several questions with respect to the origin 
of selectivity for the relevant endoproteases. 
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Recently a few of these enzymes possibly involved 
in the processing of pro-enkephalins [3-51, pro- 
opiomelanocortin [6], pro-ocytocin-neurophysin I 
[7] and pro-somatostatin [8] were characterized. 
Several types of cleavage occurring either before, 
after or else inside the pair of basic amino acids 
were observed by different authors. In some cases 
the use of peptide analogs [4,9] or the destruction 
of secondary structure by denaturation [lo] strong- 
ly suggested that other structural parameters, 
beyond the lone basic amino acid arrangements, 
might play a role in the ‘specificity’ of the recogni- 
tion by the relevant endoproteases. Among the 
above cited enzyme systems, while basic amino 
acid doublets are hydrolyzed, lone Arg or Lys 
residues in the precursors or hormone sequences 
are not. Substitution of one out of the two basic 
amino acids of a doublet by a neutral hydrophobic 
residue (Nle) or else its stereochemical modifica- 
tion (by D-Arg or D-Lys) were efficient in 
abolishing the protease action (this laboratory, un- 
published). 
To test for the possibility that the secondary 
structure around the cleavage signals may adopt 
given conformations to provide ‘selective domains’ 
to be recognized by the processing proteases we 
have evaluated the secondary structure forming 
potentialities of 94 sequences around excision sites 
enclosed in 20 polypeptide hormone precursors. 
The results allow us to formulate an hypothesis 
with respect to the existence of highly ordered do- 
mains at the processing sites. 
2. MATERIALS AND METHODS 
The secondary structure of different precursors 
was analyzed by a modification of Chou and 
Fasman’s original method which uses the 
multiplication approach instead of the arithmetic 
[ 111. a-helices and p-structures were deduced using 
tabulations of structure-formation parameters 
already determined [12]. Chou and Fasman’s 
numerical method for P-turn was adopted [13]. 
3. RESULTS AND DISCUSSION 
An inspection of the primary sequence of 20 
pro-polypeptides did not reveal any stricking 
features in the sequences around the cleavage sites 
except that among the various types of basic 
2 
doublets, the Lys-Arg pair (table 1) was found as 
the most abundant (54%). Therefore, it can be in- 
ferred that this observed selectivity of the pro- 
teolytic processing must result from the existence 
of specific enzymes (not as yet clearly defined) or 
else from the steric hindrance of some basic 
doublets, or both. To search for common struc- 
tural features that could be related to this en- 
zymatic processing, we have investigated the 
secondary structure of 20 precursors based upon 
the available primary sequence data. 
The general analysis of 94 sets of basic amino 
acids (Lys or/and Arg), whether they were pre- 
sumed to be cleaved, in vivo, or not, indicates that 
82% of them are localized in reverse turns (table 
1). According to their position in the precursors, 
with respect to the known hormonal sequences, 
these sets could be distributed among 3 sub-groups 
(either flanking, outside or inside the hormone se- 
quence). The results indicate that among 66 sets of 
Table 1 
Secondary structure analysis of sequences around basic 
amino acids in proproteins 
Precursor 
sequences 
analyzed 
Predicted 
structures 
Localization of 
basic residues 
PRO-ENKEPHALIN A (26) 
98 - 103 T K( 98)-K( 99) 
105 - 110 T K(l05)-R(106) 
111 - 118 H K(ll2)-K(l13) 
134- 139 T K(l34)-R(l35) 
140- 144 H K(l41)-K(142) 
175 - 191 T K(l86)-R(187) 
196 - 201 T K(197)-R(l98) 
210 - 216 T K(210)-R(211) 
R(217)-R(218) 
230 - 235 T K(230)-R(23 1) 
236 - 242 H K(237)-R(238) 
261 - 266 T K(261)-R(262) 
PRO-OPIOMELANOCORTIN (27) 
( - 89)-( - 55) T R( - 57)-R( - 56) 
(-47)-(-32) T R( - 43)-R( - 42) 
(-31)-(-22) H K( - 28)-R( - 27) 
(-2l)- 3 T K(- 2)-R(- 1) 
IO- 28 T K(l5)-K(16)-R(l7)-R(18) 
29 - 43 H K(40)-R(41) 
83 - 89 T K(82)-K(83) 
95 - 107 T K( 102)-R( 103) 
117 - 206 H K(131)-K(132) 
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Precursor 
sequences 
analyzed 
Table 1 (contd) 
Predicted Localization of 
structures basic residues 
PRO-THYREOLIBERIN (28) 
48- 52 T R( 51)-R( 52) 
68 - 77 H K( 75)-R( 76) 
78 - 83 T K( 81)-R( 82) 
104 -- 109 H K( 107)-R( 108) 
llO- 114 T R(113)-R(114) 
151 - 154 H K(152)-R(153) 
155 - 161 T R(158)-R(159) 
162 - 173 H K(170)-R(171) 
173 - 177 T R(176)-R(177) 
198 - 202 T K(200)-R(201) 
205 - 210 T K(206)-R(207) 
PRO-TACHYKININ (29) 
58 - 62 T R( 57) 
69 - 77 T K( 70)-R( 71) 
99 - 102 T K( 96)-R( 97) 
108- 111 T K( 109)-R( 110) 
123 - 127 T R(127)-R(128)-R(129)-K(l30) 
PRO-RELAXIN (30) 
25- 31 T K( 29)-R( 30) 
94 - 108 T K(105)-K(106) 
126- 137 T K(134)-K(135)-R(136)-R(137) 
151 - 154 T K(153)-R(154) 
PRO-VlP/PHM (31) 
71 - 91 T R( 80) 
92- 110 H K(lOO)-K(lO1) 
K(109)-R(ll0) 
111- 121 T K( 123)-R(124) 
136- 152 H R(138)-K(139) 
K(144)-K(145) 
153 - 160 T K(154)-R(155) 
PRO-INSULIN-LIKE GROWTH FACTOR 11 (32) 
21- 42 T R( 37)-R( 38) 
60 - 66 T R( 68) 
95 - 136 H R(103)-R(104) 
R(113)-R(114) 
K(129)-R(130) 
137 - 180 T R(179)-K(180) 
PRO-RENIN (33) 
27 - 59 H K( 34)-K( 35) 
60 - 64 T K( 62)-R( 63) 
298 - 318 H K(3 lO)-R(3 11) 
332 - 354 T R(352)-R(353) 
373 - 401 H R(382)-K(383) 
PRO-GLUCAGON (34) 
53 - 65 T K( 51)-R( 52) 
66- 78 H R( 69)-K( 70) 
Precursor 
sequences 
analyzed 
Predicted 
structures 
Localization of 
basic residues 
79 - 84 T K( 82)-R( 83) 
90- 101 T K( 89)-R( 90) 
112 - 123 H R(122)-R(123) 
PRO-CORTICOTROPIN-RELEASING FACTOR (35) 
121 - 131 T R(123)-R(124) 
154- 160 T R(152)-R(153) 
186- 189 T R( 188)-K( 189) 
190- 196 H R(196) 
PRO-GROWTH HORMONE-RELEASING FACTOR 
(36) 
27- 38 H R(30)-R(31) 
39 - 43 T R(42)-K(43) 
44 - 62 H R(5 l)-K(52) 
72 - 77 T R(77) 
PRO-INSULIN (37) 
19- 31 T R(3 l)-R(32) 
53- 66 T K(64)-R(65) 
PRO-PARATHYROID HORMONE (38) 
(- lo)-(- 5) T K( - 3)-K( - 2)-R( - 1) 
14- 41 H R(25)-K(26)-K(27) 
42 - 54 T R(52)-K(53)-K(54) 
PRO-UROTENSIN (39) 
loo- 109 T K(lOl)-R(102) 
136 - 141 T R(137)-K(138) 
142 - 145 T K(145) 
PRO-SOMATOSTATIN (22) 
(- 16)- 2 T R( - 15) 
R( - 2)-K( - 1) 
PRO-VASOPRESSIN-NEUROPHYSIN II (40) 
6- 13 T K( 1 I)-R( 12) 
101 - 107 E R(105)-R(106) 
108 - 123 T R(108) 
PRO-OCYTOCIN-NEUROPHYSIN I (40) 
6- 13 T K(ll)-R(12) 
PRO-CALCITONIN (23) 
72 - 87 T K( 83)-R( 84) 
115 - 120 T K(118)-K(119)-R(120) 
PRO-CALCITONIN GENE RELATED PEPTIDE 
(23) 
82 - 88 T K( 81)-R( 82) 
110 - 123 T R(121)-R(122)-R(123) 
PRO-GONADOTROPIN-RELEASING HORMONE 
(41) 
(-ll)-(- 1) T K( - 2)-R( - 1) 
49- 53 T K(54)-K(55) 
3 
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basic amino acids, flanking the hormone se- 
quences, all of them are directly included in reverse 
turns or immediately adjacent to such structures 
(at - 1 or - 2 amino acid). Therefore it can be in- 
ferred that the situation of cleavage loci signals in 
P-turns is a minimal requirement for the recogni- 
tion by convertases or maturases. 
In contrast, among 17 sets of basic residues 
situated inside the hormone sequences, 10 were 
found either in an a-helix or a &sheet. They could 
be expected to be preserved for cleavage if these 
structures are conserved after release of the known 
hormone sequence. The remaining 7 sets were 
found in the region with &turn forming capacity. 
In vivo data about the possible role of these signals 
for proteolytic cleavage are still lacking. On the 
basis of these results, 92% out of the 83 above 
described sets are to be predicted in suitable struc- 
tures by this method. Finally, 11 sets of basic 
amino acids were localized outside the hormone se- 
quence in the precursors. If we assume the above 
hypothesis, 54% of them could be predicted as 
cleaved because situated in turn structures while 
the remaining 46% should not be. 
We can predict that the presence of basic pairs 
into high &turn forming capacity sequences is 
compatible with recognition by selective endo- 
proteases and that they are consequently expected 
to be cleaved under adequate conditions. This is 
supported by the observations, from literature 
data, that this prerequisite is fulfilled and that such 
loci are indeed cleaved. 
This general tendency of cleavage sites, to be 
located in a &turn, is in agreement with the func- 
tions attributed generally to these structures [14]: 
i.e. (i) they provide a flexible region to the cleavage 
sites and therefore allow accessibility for en- 
zymatic processing and (ii) in cases where the ,&- 
turn is adjacent to the cleavage sites, these regions 
may provide a structure in the nascent polypeptide 
chain to trigger the processing. On another hand, 
the unprocessed sequences appear to be included in 
a rigid conformation @-helix or P-sheet structures) 
and thus represent poor substrates for proteolytic 
enzymes. However, after release from precursors, 
small hormones, such as VIP, glucagon or 
lipotropin, do not appear to possess secondary 
structure in dilute solutions [15]. Under such con- 
ditions, they could be cleaved at their internal basic 
residues. On the basis of these data, one might sug- 
gest that: (i) to preserve their full sequences from 
cleavage, the hormones self-associate to induce 
their secondary structure [16] or (ii) these active 
peptides are indeed cleaved in vivo under certain 
conditions but their fragments still remain to be 
characterized. 
Considering 57 analyzed domains (table 2), cor- 
responding to loci cleaved in vivo, it can be 
calculated that the probability for predicting the 
structure H/T/H is the highest (48%) while the 
others (H/T/E; E/T/H; E/T/E) rank respectively 
for 18%, 24% and 10%. These values were 
calculated assuming that certain domains may be 
predicted to adopt either an a-helix or a P-sheet 
conformation. Since cu-helices can be expected to 
be generally more exposed than p-sheets in the ter- 
tiary structure of proteins [ 17,181, this implies that 
the sequential order in cleavage may be determined 
by the above defined type of interactions. 
Out of the 48 analyzed doublets (table 2), known 
to be cleaved in vivo, 73% were of the type Lys- 
Arg. They themselves are distributed among 
H/T/H (56%), H/T/E (18%), E/T/H (22%) and 
E/T/E (4Yo). In a similar way, if we compare the 
localization of Lys-Arg pairs, in a given structure, 
to other doublets (Arg-Lys, Lys-Lys and Arg-Arg), 
roughly 70-75% of the doublets belong to the Lys- 
Arg type. This indicates that no mutual relation- 
Table 2 
Relative percentage of various basic amino acids combination i  different secondary structures 
Type of secondary structures % of basic residues 
cleaved in vivo 
% of K-R related to 
other doublets 
% of K-R found in each 
structure 
H/T/H 
H/T/E 
E/T/H 
E/T/E 
48% 
18% 
24% 
10% 
75% 
73% 
72% 
70% 
56% 
18% 
22% 
4% 
4 
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ships exist between Lys-Arg doublets and any 
secondary structure, except that the predominance 
of Lys-Arg doublets in H/T/H structures may ex- 
plain the preferential cleavage of Lys-Arg doublets 
in multifunctional precursors. 
As a corollary from such observations, it can be 
proposed that (i) the basic doublet is necessary but 
it does not appear to play a critical role in specify- 
ing the type of secondary structure flanking the /3- 
turn, (ii) the degree of exposure of a processing do- 
main depends upon its secondary structure. 
Therefore, the unfolding of the precursor in a se- 
quentially ordered process may regulate the 
cleavage at the basic pairs. (iii) Only a few pro- 
teolytic enzymes may participate in the processing 
of these peptide hormone precursors. For example, 
the somatostatin-28 convertase of the rat brain 
cortex [7,19] while active in converting somato- 
statin- (S-28) into its S-28 (1-12) and S-14 NH2- 
and COOH-terminal domains could not release the 
hormones from their 12 kDa common precursor 
[19]. Similarly, in the case of pro-opiomelano- 
cortin, processing products appear in vivo in a 
given order 1201. This implies that the basic amino 
acids at the cleavage loci are necessary for the 
hydrolysis to occur but they can hardly explain 
both the enzyme specificity and the sequence of 
events. 
Comparative examination of the primary struc- 
tures of the cleavage domains in the series of both 
pro-ocytocin-neurophysin I and pro-vasopressin- 
neurophysin II among 6 animal species [21] reveals 
that some variations of the amino acid sequences 
occur at position 8, 14, 15, 16, 18, 19 and 21 of 
either precursors (i.e. amino acid 8 of vasopressin 
and residues 2-4, 6, 7 and 9 of neurophysins). 
Nevertheless prediction for secondary structure 
formation indicates the conservation of a ,& 
sheet/&turn/a-helix domain (this laboratory, un- 
published). Similarly, comparison of the amino 
acid sequences of several pro-somatostatin-28 
molecules indicates high variation in the S-28 
(l-> 12) NHz-terminal fragment preceding the 
Arg-Lys pair. But these variances in amino acid SB- 
quences have no significant effect on the conserva- 
tion of a highly ordered secondary structure 1221. 
The same conclusion applied (this laboratory, un- 
published) when comparing pro-calcitonin and 
pro-CGRP [23] through various species. 
Finally, in the case of the pro-vasopressin- 
neurophysin II and pro-ocytocin-neurophysin I
genes [24] for instance, it can be observed that a 
single exon (exon-I) encodes for the whole 
NHz-terminal domain of the precursor (l-> 21) in- 
cluding the nonapeptide hormone sequence, the 
processing sequence and the first nine amino acids 
of neurophysins [24,6]. Preliminary examination 
of the gene structure for a few prohormones [25] 
indicates that in all cases the hormone(s) se- 
quence(s) is/are coded by a single exon which also 
codes for the mRNA specifying the processing do- 
mains either preceding, following or flanking the 
latter. Further elucidation of other prohormones 
gene structures will indicate if this is, as can be ex- 
pected, a general rule. 
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